Tumor escape from immune recognition: Loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6

Clinical Cancer Research

Volumn 2, Issue 4, 1996, Pages 641-652

  Maeurer, Markus J ^a,d   Gollin, Susanne M ^a   Storkus, Walter J ^a   Swaney, William ^a   Karbach, Julia ^c   Martin, Dina ^a   Castelli, Chiara ^b   Salter, Russell ^a   Knuth, Alex ^c   Lotze, Michael T ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c KRANKENHAUS NORDWEST   (Germany)

^d Institutshochhaus Augustusplatz ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HLA A2 ANTIGEN; MELANOMA ANTIGEN; MEMBRANE ANTIGEN;

ARTICLE; CHROMOSOME 6P; CHROMOSOME REARRANGEMENT; CONTROLLED STUDY; DOWN REGULATION; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; IMMUNOGENICITY; MELANOMA CELL; PRIORITY JOURNAL; TUMOR CELL LINE;

ANTIGENS, NEOPLASM; ATP-BINDING CASSETTE TRANSPORTERS; CHROMOSOMES, HUMAN, PAIR 6; GENE REARRANGEMENT; GENE TRANSFER TECHNIQUES; HLA-A2 ANTIGEN; HUMANS; INTERFERON TYPE II; MELANOMA; NEOPLASM PROTEINS; RNA, MESSENGER; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED; VIRAL MATRIX PROTEINS;

EID: 15844369201     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Garrido, F., Cabrera, T., Concha, A., Glew, S., Riuz-Cabello, F., and Stem, P. L. Natural history of HLA expression during tumour development Immtmol. Today, 14: 491-499, 1993.
2. Cordon-Cardo, C., Fiks, Z., Drobnjak, M, Moreno, C., Eisenbach, L., and Feldman, M. Expression of HLA-A,B,C antigens on primary and metastatic tumor cell populations of human carcinomas. Cancer Res., 57: 6372-6378, 1991.
3. Natali, P. G., Bigotti, A., Nicotra, M. R., Viora, M., Manfredi, D., and Ferrone, S. Distribution of human class I (HLA-A.B.C) histocompatibility antigens in normal and malignant tissues of nonlymphoid origin. Cancer Res., 44: 4679-4687, 1984.
4. Ruiter, D. T., Mattijssen, V., Brocker, E-B., and Ferrone, S. MHC antigens in human melanomas. Semin. Cancer Biol., 2: 35-42, 1991.
5. Cromme, F. V., Airey, J., Heemels, M-T., Ploegh, H. L., Keating, P. J . Stem, P. L., Meijer C. J. L. M., and Walboomers J. M. M. Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas. J. Exp. Med., 179: 335-340, 1994.
6. Restifo, N. P., Esquivel, F., Kawakami, Y., Yewdell, J M., Mule, J. J., Rosenberg, S. A., and Benmck J. R. Identification of human cancers deficient in antigen processing. J. Exp. Med., 177: 265-272, 1993
7. Browning, M. J., Krausa, P., Rowan, A., Bicknell, D. C., Bodmer, J. G., and Bodmer, W. F. Tissue typing the HLA-A locus from genomic DNA by sequence-specific PCR: comparison of HLA genotype and surface expression on colorectal cancer tumor cell lines. Proc. Natl. Acad. Sci. USA, 90: 2842-2845, 1993.
8. Ferrone S., and Marincola, F. M. Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance. Immunol. Today, 76: 487-494, 1995.
9. 1-microglobulin expression. J. Clin. Invest., 87: 284-289, 1991.
10. 2,-microglobulin messenger RNA. J. Clin. Invest., 97: 684-689, 1993.
11. Restifo, N. P., Esquivel, F., Asher, A. L., Stotter, H., Barth, R. J., Bennink, J. R., Mulé, J. J., Yewdell, J. W., and Rosenberg, S. A. Defective presentation of endogenous antigens by a murine sarcoma: implications for the failure of an anti-tumor response. J. Immunol., 147: 1453-1460, 1991.
12. + T lymphocytes. Cell, 77: 525-535, 1994.
13. Beersma, M. F. C., Bijimakers, M. J. E., and Ploegh. H. L. Human cytomegalovirus downregulates HLA-class I expression by reducing the stability of class I chains. J. Immunol., 151: 4455-4464, 1993.
14. Hill, A., Jugovic, P., York, I., Russ, G., Bennink, J., Yewdell, J., Ploegh, H., and Johnson, D. Herpes simplex virus turns off the TAP to evade host immunity. Nature (Lond.), 375: 411-415, 1995.
15. Fruh, K., Ahn, K., Djaballah, H., Sempe, P., van Endert, P. M., Tampe, R., Peterson, P. A., and Yang, Y. A viral inhibitor of peptide transporters for antigen presentation. Nature (Lond.), 375: 415-418, 1995.
16. Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Rivoltini, L., Topalian, S. L., Miki T., and Rosenberg, S. A. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor, Proc. Natl. Acad. Sci. USA, 91: 3515-3519, 1994.
17. Coulie, P. G., Brichard, V., VanPel, A., Wolfel, T., Schneider, J., Traversart, C., Mattel, S., De Plaen, E., Lurquin, C., Szikora, J-P., Renauld, J-C., and Boon, T. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med., 180: 35-42, 1994.
18. + cytotoxic T lymphocytes. J. Exp. Med., 181: 363-368, 1995.
19. Kawakami, Y., Eliyahu, S., Delgado, C. K., Robbins, P. F., Sakaguchi, K., Appella, E., Yanelli J. R., Adema, G. J., Kimi, T., and Rosenberg, S. A Identification of melanoma antigens recognized by tumor infiltrating lymphocytes associated with in vivo tumor rejection. Proc. Natl. Acad. Sci. USA, 91: 6458-6462, 1994.
20. Bakker, A. B. H., Schreurs, M. W J., de Boer, A. J., Kawakami, Y., Rosenberg, S. A., Adema, G. J., and Figdor, C. G. Melanocyte lineage-specific antigen gp 100 is recognized by melanoma derived tumor infiltrating lymphocytes. J. Exp. Med., 179: 1005-1009, 1994.
21. Cox, A. L., Skipper, J., Chen, Y., Henderson, R. A., Darrow, T. L., Shabanowitz, J., Engelhard V. H., Hunt, D. F., and Slingluff, C. L. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science (Washington DC), 264: 716-719, 1994.
22. Brichard, V., Van Pel, A., Wolfel, T., Wolfel, C., De Plaen, E. Lethe, B , Coulie, P., and Boon, T. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med., 178: 489-495, 1993.
23. Van der Bruggen, P., Bastin, J., Gajewski, T., Coulie, P. G., Boel, P., De Smet, C., Traversari, C., Townsend, A., and Boon, T. A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Eur. J. Immunol., 24. 3038-3043, 1994.
24. Wang, R-F., Robbins, P. F., Kawakami, Y., Kang, X-Q., and Rosenberg, S. A. Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes. J. Exp. Med., 181: 799-804, 1995.
25. Robbins, P. F., El-Gamil, M., Kawakami, Y., and Rosenberg, S. A. Recognition of tyrosinase by rumor-infiltrating lymphocytes from a patient responding to immunotherapy. Cancer Res., 54: 3124-3126, 1994.
26. Van der Bruggen, P., Szikora, J-P., Boel, P., Wildmann, C., Somville, M., Sensi, M., and Boon, T. Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLACw * 16018. Eur. J. Immunol., 24: 2134-2140, 1994.
27. Van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van Den Eynde, B., Knuth, A., and Boon, T. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science (Washington DC), 254: 1643-1647, 1991.
28. Gaugler, B., Van den Eynde, B., van der Bruggen, P., Romero, P., Gaforio, J. J., De Plaen, E., Lethe, B., Brasseur, F., and Boon, T. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes J. Exp. Med., 179: 921-930, 1994.
29. Elder, E. M., and Whiteside, T. L. Processing of tumors for vaccine and/or tumor infiltrating lymphocytes. In: N. R. Rose, E. Conway de Macaio, J. L. Fahey, H. Friedman, and G. M. Penn (eds.), Manual of Clinical laboratory Immunology, Ed. 4, pp. 817-819. Washington, DC: American Society for Microbiology, 1992.
30. Maeurer, M. J., Hurd, S., Martin, D. M., Storkus, W. J., and Lotze, M. T. Cytolytic T-cell clones defined HLA-A2 restricted human cutaneous melanoma peptide epitopes - correlation with T-cell receptor usage. Cancer J. Sci. Am., 1: 162-170, 1995.
31. Storkus, W. J., Zeh, H. J., III, Maeurer, M. J., Salter, R. D., and Lotze, M. T. Identification of human melanoma peptides recognized by class I-restricted tumor infiltrating lymphocytes. J. Immunol., 151: 3719-3727, 1993.
32. Mitelman, F (ed.). International System for Cytogenetic Nomenclature (1991) Guidelines for Cancer Cytogenetics: Supplement to the International System for Cytogenetic Nomenclature. Basel: Karger, 1991.
33. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
34. Danos, O., and Mulligan, R. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc. Natl. Acad. Sci. USA. 85: 6460-6464, 1988.
35. Wolfel, T., Klehmann, E. Muller. C., Schutt, K., Meyer zum Buschenfelde, K-H., and Knuth, A. Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibiliry leukocyte antigen A2 as a restriction element for three different antigens. J. Exp. Med., 170: 797-808, 1989.
36. Kageshita, T., Wang, Z., Calorini, L., Yoshii, A., Kimura, T., Ono, S., Gattoni-Celli, S., and Ferrone, S. Selective loss of human leukocyte class I allospecificities and staining of melanoma cells by monoclonal antibodies recognizing monomorphic determinants of class I human leukocyte antigen. Cancer Res., 53: 3349-3354, 1993.
37. Marincola, F. M., Shamamian, P., Alexander, R. B., Gnarra, J. R., Turetskaya, R. L., Nedospasov, S. A., Simonis, T. B., Taubenberger, J. K., Yanelli, J., Mixon, A., Restifo, N. P., Herlyn, M., and Rosenberg, S. A. Loss of HLA haplotype and B locus downregulation in melanoma cell lines. J. Immunol., 153: 1225-1237, 1994.
38. Trent, J. M., Stanbridge, E. J., McBride, H. L., Meese, E., Casey, G., Araujo. D. E., Witkowski, C. M., and Nagle, R. B. Tumorigenicity in human melanoma cell lines controlled by introduction of human chromosome 6. Science (Washington DC), 247: 568-571, 1990.
39. Ting, J. P-Y., and Baldwin, A. S. Regulation of MHC gene expression. Curr. Opin. Immunol., 5: 8-16, 1993.
40. Hakem, R., LeBouteiller, P., Jezo-Bremond, A., Harper, K., Campese, D., and Lemonnier, F. Differential regulation of HLA-A3 and HLA-B7 MHC class 1 genes is due to two nucleotide differences in their IFN responsive element. J. Immunol., 147: 2384-2390, 1991.
41. Cereb, N., and Yang, S. Y. The regulatory complex of HLA class I promoters exhibits locus-specific conservation with limited allelic variation. J. Immunol., 152: 3873-3883, 1994.
42. Henderson, R. A., Michel, H., Sakaguchi, K., Chabanowitz, J., Appella, E., Hunt. D., and Engelhard, V. HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation. Science (Washington DC), 255; 1264-1266, 1992.
43. Santos-Aguado, J., Barbosa, J. A., Biro, P. A., and Strominger, J. L. Molecular characterization of serologic recognition sites in the human HLA-A2 molecule. J. Immunol., 141: 2811-2818, 1988.
44. Zeh, H. J., III, Leder, G. H., Lotze, M. T., Salter R. D., Tector, M., Stuber, G., Modrow, S., and Storkus. W. J. Flow-cytometric determination of peptide-class I complex formation. Identification of p53 peptides that bind to HLA-A2. Hum. Immunol., 39: 79-86, 1994.
45. Bodmer, H., Ogg, G., Goten, F., and McMichael, A. Anti-HLA-A2 antibody-enhancement of peptide association with HLA-A2 as detected by cytotoxic T lymphocytes. Nature (Lond.), 342: 443-446, 1989.